LAZARD ASSET MANAGEMENT LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$430
+92.0%
55,428
+138.0%
0.00%
Q2 2023$224
+489.5%
23,291
+162.7%
0.00%
Q4 2022$38
-99.9%
8,865
-1.2%
0.00%
Q3 2022$67,000
+26.4%
8,971
+69.3%
0.00%
Q2 2022$53,000
-18.5%
5,3000.0%0.00%
Q1 2022$65,000
+44.4%
5,300
+164.7%
0.00%
Q4 2021$45,0000.0%2,002
-43.1%
0.00%
Q1 2021$45,0003,5200.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders